Table 1.
Participant demographic information
| Variables | Overall participants | Qualitative analysis | NAC group | Placebo group |
|---|---|---|---|---|
| N | 53 | 47 | 13 | 13 |
| Cohort % | 100% | 89% | 25% | 25% |
| Gender | ||||
| Female | 29 (55%) | 27 (57%) | 8 (62%) | 7 (54%) |
| Male | 24 (45%) | 20 (43%) | 5 (38%) | 6 (46%) |
| Age | ||||
| Total | 29.8 ± 17.6 | 29.6 ± 17.1 | 32.8 ± 16.3 | 23.8 ± 17.6 |
| Adults (>18) |
35 (66%) 39.9 ± 12.7 |
31 (66%) 39.4 ± 12.4 |
9 (69%) 42.4 ± 7.3 |
6 (46%) 39.7 ± 13.2 |
| Peds (<18) |
18 (34%) 10.2 ± 2.7 |
16 (34%) 10.5 ± 2.8 |
4 (31%) 11.0 ± 2.9 |
7 (54%) 10.1 ± 2.0 |
| Ethnicity | ||||
| White | 47 (89%) | 42 (89%) | 12 (92%) | 13 (100%) |
| Black | 6 (11%) | 5 (11%) | 1 (8%) | 0 (0%) |
| Location | ||||
| Northeast | 10 (19%) | 10 (21%) | 1 (8%) | 3 (23%) |
| Southeast | 9 (17%) | 9 (19%) | 5 (39%) | 2 (15%) |
| Midwest | 10 (19%) | 5 (11%) | 2 (15%) | 0 (0%) |
| Southwest | 4 (7 %) | 4 (9 %) | 2 (15%) | 1 (8%) |
| West | 10 (19%) | 10 (21%) | 2 (15%) | 2 (15%) |
| Abroad | 10 (19%) | 9 (19%) | 1 (8%) | 5 (39%) |